無料プレビュー

ShockWave Medical, Inc. (SWAV) · NASDAQ Global Select

プロフィール

ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a profe

主要指標

株価: $334.75 (-0.02%)
時価総額: 126億ドル
PER（今期予想）: 67.8
PBR: 18.4
配当利回り: —
52週レンジ: $157.00 – $334.90
業種: Healthcare / Medical - Devices
上場: NASDAQ Global Select
構成銘柄: —

比較会社: ABT Abbott Laboratories、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、BDX Becton, Dickinson and Company、EW Edwards Lifesciences Corporation、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2024-08-05 · 更新: 2026-10-09